Soluble factors produced by activated CD4+ T cells modulate EBV latency.

Area of Science:

• Immunology
• Virology
• Cell Biology

Background:

• Epstein-Barr virus (EBV) establishes lifelong latency in memory B cells.
• EBV exhibits distinct latency patterns, including silent (latency I/0) and proliferative (latency III) states.
• Understanding the regulation of EBV latency is crucial for controlling viral persistence.

Purpose of the Study:

• To investigate the role of CD4(+) T cells in regulating EBV latency.
• To determine how CD4(+) T cells influence EBV gene expression and B-cell proliferation.

Main Methods:

• Co-culture of lymphoblastoid cell lines (LCLs) with autologous or allogeneic CD4(+) T cells.
• Transwell system experiments to assess cell contact-independent mechanisms.
• Neutralizing experiments using cytokines like IL-21 and soluble CD40L.

Main Results:

• Activated CD4(+) T cells down-regulated EBNA2 and up-regulated LMP1 expression in LCLs.
• T-cell interaction reduced LCL proliferation and down-regulated the latency III promoter (Cp).
• Soluble factors, including IL-21 and CD40L, mediated these regulatory effects.

Conclusions:

• CD4(+) T cells play a significant role in controlling EBV-induced B-cell proliferation.
• Soluble mediators released by T cells are key in modulating EBV latency.
• This study reveals a novel mechanism of T-cell-mediated control over EBV infection.